.png){kind=icon}
.png){kind=icon}
Return
Effect of vanzacaftor/tezacaftor/ivacaftor on cystic fibrosis nasal epithelial cells and intestinal organoids compared to elexacaftor/tezacaftor/ivacaftor
.png){kind=icon}
PRE
AI
B
M
Š
F
V
D
P
DOI：10.1016/j.rmed.2026.108741.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background: The triple combination of vanzacaftor/tezacaftor/deutivacaftor (VAN/TEZ/D-IVA) is a new alternative to the established therapy with elexacaftor/tezacaftor/ivacaftor (ELX/TEZ/IVA) in people with cystic fibrosis (pwCF). While both therapies show similar effects on lung function, VAN/TEZ/D-IVA further reduces sweat chloride concentrations. We aimed to explore the potential of triple combination VAN/TEZ/IVA to enhance the CFTR function in vitro. Methods: Primary nasal epithelial cells (HNECs) and patient-derived intestinal organoids (PDIOs), both obtained from the same 12 F508del/F508del pwCF, were pretreated with ELX/TEZ, VAN/TEZ or left untreated. The response to the CFTR modulators was assessed using the transepithelial short-circuit current (ISC) measured by the Ussing chamber method after the sequential addition of amiloride, forskolin (Fsk) with 3-isobutyl-1-methylxanthine (IBMX), IVA, CFTRinh-172 and ATP to HNECs from pwCF and 10 healthy donors (WT). Delta CFTRinh-172 ISC was used for assessment of CFTR activity (expressed as percentage of WT activity). The response of PDIOs to the CFTR modulators was tested using the forskolin induced swelling (FIS) assay. CFTR activity was expressed as area under the curve (AUC). Results: Significant differences in CFTR-mediated chloride ISC were observed between untreated, ELX/TEZpretreated and VAN/TEZ-pretreated HNECs from pwCF. CFTR function was restored to 45% of WT levels with ELX/TEZ/IVA and to 67% with VAN/TEZ/IVA. Using the FIS assay, effects of both triple combinations on swelling of PDIOs were comparable. Conclusions: VAN/TEZ/IVA demonstrated superior CFTR functional rescue in F508del/F508del HNECs than ELX/ TEZ/IVA. These findings highlight the greater discriminatory power of airway epithelial electrophysiology compared to PDIOs when comparing highly effective CFTR modulator therapies.
Keywords:
CFTR modulator therapy
Vanzacaftor
Airway liquid interface
Ussing chamber
Intestinal organoids
Forskolin induced swelling assay
Journal
IF:
3.1
Papers:
7.8K
Citations:
1.4W
Organization
Cited Papers